EOM Pharmaceutical Holdings, Inc. (IMUC) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
30721 RUSSELL RANCH ROAD WESTLAKE VILLAGE, CA 91362 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2018 MRQ | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 6,629,870 | 11,437,118 | 22,604,481 | 23,222,296 | 27,646,351 | 26,216,668 | |||
| Cash and cash equivalents | 6,629,870 | 11,437,118 | 22,604,481 | 23,222,296 | 27,646,351 | 26,216,668 | |||
| Prepaid expense | 1,186,186 | 1,158,632 | ✕ | ||||||
| Other current assets | 378,787 | 791,485 | 797,425 | 1,219,873 | 763,299 | ✕ | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 714,508 | ||
| Total current assets: | 7,008,657 | 13,414,789 | 24,560,538 | 24,442,169 | 28,409,650 | 26,931,176 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 568 | 109,823 | 180,922 | 47,365 | 66,442 | 76,289 | |||
| Prepaid expense | 1,309,648 | 1,115,657 | ✕ | ||||||
| Deposits noncurrent assets | 1,955,514 | 4,176,280 | 11,736 | ||||||
| Deferred costs | 48,977 | 105,563 | |||||||
| Other noncurrent assets | 583,464 | 464,585 | ✕ | ||||||
| Other undisclosed noncurrent assets | 100,216 | ||||||||
| Total noncurrent assets: | 568 | 3,475,201 | 5,521,836 | 736,392 | 531,027 | 88,025 | |||
| TOTAL ASSETS: | 7,009,225 | 16,889,990 | 30,082,374 | 25,178,561 | 28,940,677 | 27,019,201 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,360,754 | 3,238,943 | 2,269,398 | 1,289,199 | 1,402,273 | 1,098,307 | |||
| Employee-related liabilities | 290,516 | 1,109,864 | 790,487 | 334,527 | 357,265 | 309,345 | |||
| Accounts payable | 1,774,626 | 1,342,126 | 1,161,258 | 322,002 | 861,026 | 732,851 | |||
| Accrued liabilities | 295,612 | 786,953 | 317,653 | 632,670 | 183,982 | 56,111 | |||
| Total current liabilities: | 2,360,754 | 3,238,943 | 2,269,398 | 1,289,199 | 1,402,273 | 1,098,307 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 7,519,301 | 6,092,680 | |||||||
| Total noncurrent liabilities: | 7,519,301 | 6,092,680 | |||||||
| Total liabilities: | 2,360,754 | 10,758,244 | 8,362,078 | 1,289,199 | 1,402,273 | 1,098,307 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 4,648,471 | 6,131,746 | 21,720,296 | 23,291,643 | 26,473,594 | 23,068,014 | |||
| Common stock | 4,191 | 344 | 9,031 | 6,360 | 5,754 | 5,150 | |||
| Additional paid in capital | 121,087,939 | 102,354,844 | 95,849,005 | 84,632,209 | 78,437,233 | 66,231,694 | |||
| Accumulated deficit | (116,443,659) | (96,223,442) | (74,137,740) | (61,346,926) | (51,969,393) | (43,168,830) | |||
| Warrants and rights outstanding | 597,719 | 1,064,810 | 2,852,880 | ||||||
| Other undisclosed equity, attributable to parent | (597,719) | (1,064,810) | (2,852,880) | ||||||
| Total equity: | 4,648,471 | 6,131,746 | 21,720,296 | 23,291,643 | 26,473,594 | 23,068,014 | |||
| Other undisclosed liabilities and equity | 597,719 | 1,064,810 | 2,852,880 | ||||||
| TOTAL LIABILITIES AND EQUITY: | 7,009,225 | 16,889,990 | 30,082,374 | 25,178,561 | 28,940,677 | 27,019,201 | |||
Income Statement (P&L) (USD)
| 6/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Gross profit: | (720,395) | (98,713) | ||||||
| Operating expenses | (21,153,444) | (24,112,125) | (15,513,091) | (9,858,541) | (8,739,924) | (11,727,818) | ||
| Operating loss: | (21,153,444) | (24,112,125) | (15,513,091) | (9,858,541) | (9,460,319) | (11,826,531) | ||
| Nonoperating income (expense) (Investment Income, Nonoperating) | 4,680 | 3,836,779 | 2,945,121 | 543,691 | 659,756 | (2,271,314) | ||
| Interest and debt expense | 6,836,757 | (1,311,836) | (133,905) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (397,294) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (14,312,007) | (21,587,182) | (12,701,875) | (9,314,850) | (8,800,563) | (14,495,139) | ||
| Other undisclosed loss from continuing operations before income taxes | (498,520) | (88,939) | (62,683) | |||||
| Loss from continuing operations: | (14,312,007) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
| Loss before gain (loss) on sale of properties: | (14,312,007) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
| Net loss attributable to parent: | (14,312,007) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
| Other undisclosed net loss available to common stockholders, basic | (3,369,646) | |||||||
| Net loss available to common stockholders, diluted: | (17,681,653) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
Comprehensive Income (USD)
| 6/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (14,312,007) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
| Comprehensive loss, net of tax, attributable to parent: | (14,312,007) | (22,085,702) | (12,790,814) | (9,377,533) | (8,800,563) | (14,495,139) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.